Compile Data Set for Download or QSAR
maximum 50k data
Found 260 Enz. Inhib. hit(s) with all data for entry = 7195
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM180490(US8772323, 52)
Affinity DataEC50:  189nMpH: 7.4 T: 2°CAssay Description:MIN6 cells [Miyazaki J et al. Endocrinology. 1990 July; 127(1):126-32] were stably transfected with an expression vector for human GPR119 cDNA (Acc. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM180491(US8772323, 53)
Affinity DataEC50:  205nMpH: 7.4 T: 2°CAssay Description:MIN6 cells [Miyazaki J et al. Endocrinology. 1990 July; 127(1):126-32] were stably transfected with an expression vector for human GPR119 cDNA (Acc. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM180492(US8772323, 54)
Affinity DataEC50:  145nMpH: 7.4 T: 2°CAssay Description:MIN6 cells [Miyazaki J et al. Endocrinology. 1990 July; 127(1):126-32] were stably transfected with an expression vector for human GPR119 cDNA (Acc. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM180493(US8772323, 55)
Affinity DataEC50:  486nMpH: 7.4 T: 2°CAssay Description:MIN6 cells [Miyazaki J et al. Endocrinology. 1990 July; 127(1):126-32] were stably transfected with an expression vector for human GPR119 cDNA (Acc. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM180494(US8772323, 56)
Affinity DataEC50:  170nMpH: 7.4 T: 2°CAssay Description:MIN6 cells [Miyazaki J et al. Endocrinology. 1990 July; 127(1):126-32] were stably transfected with an expression vector for human GPR119 cDNA (Acc. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM180495(US8772323, 57)
Affinity DataEC50:  37nMpH: 7.4 T: 2°CAssay Description:MIN6 cells [Miyazaki J et al. Endocrinology. 1990 July; 127(1):126-32] were stably transfected with an expression vector for human GPR119 cDNA (Acc. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM180496(US8772323, 58)
Affinity DataEC50:  76nMpH: 7.4 T: 2°CAssay Description:MIN6 cells [Miyazaki J et al. Endocrinology. 1990 July; 127(1):126-32] were stably transfected with an expression vector for human GPR119 cDNA (Acc. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM180497(US8772323, 59)
Affinity DataEC50:  1.59E+3nMpH: 7.4 T: 2°CAssay Description:MIN6 cells [Miyazaki J et al. Endocrinology. 1990 July; 127(1):126-32] were stably transfected with an expression vector for human GPR119 cDNA (Acc. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM180498(US8772323, 60)
Affinity DataEC50:  639nMpH: 7.4 T: 2°CAssay Description:MIN6 cells [Miyazaki J et al. Endocrinology. 1990 July; 127(1):126-32] were stably transfected with an expression vector for human GPR119 cDNA (Acc. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM180499(US8772323, 61)
Affinity DataEC50:  342nMpH: 7.4 T: 2°CAssay Description:MIN6 cells [Miyazaki J et al. Endocrinology. 1990 July; 127(1):126-32] were stably transfected with an expression vector for human GPR119 cDNA (Acc. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM180500(US8772323, 62)
Affinity DataEC50:  552nMpH: 7.4 T: 2°CAssay Description:MIN6 cells [Miyazaki J et al. Endocrinology. 1990 July; 127(1):126-32] were stably transfected with an expression vector for human GPR119 cDNA (Acc. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM180501(US8772323, 63)
Affinity DataEC50:  324nMpH: 7.4 T: 2°CAssay Description:MIN6 cells [Miyazaki J et al. Endocrinology. 1990 July; 127(1):126-32] were stably transfected with an expression vector for human GPR119 cDNA (Acc. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM180502(US8772323, 64)
Affinity DataEC50:  237nMpH: 7.4 T: 2°CAssay Description:MIN6 cells [Miyazaki J et al. Endocrinology. 1990 July; 127(1):126-32] were stably transfected with an expression vector for human GPR119 cDNA (Acc. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM180503(US8772323, 65)
Affinity DataEC50:  426nMpH: 7.4 T: 2°CAssay Description:MIN6 cells [Miyazaki J et al. Endocrinology. 1990 July; 127(1):126-32] were stably transfected with an expression vector for human GPR119 cDNA (Acc. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM180504(US8772323, 66)
Affinity DataEC50:  112nMpH: 7.4 T: 2°CAssay Description:MIN6 cells [Miyazaki J et al. Endocrinology. 1990 July; 127(1):126-32] were stably transfected with an expression vector for human GPR119 cDNA (Acc. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM180505(US8772323, 67)
Affinity DataEC50:  51nMpH: 7.4 T: 2°CAssay Description:MIN6 cells [Miyazaki J et al. Endocrinology. 1990 July; 127(1):126-32] were stably transfected with an expression vector for human GPR119 cDNA (Acc. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM180506(US8772323, 68)
Affinity DataEC50:  60nMpH: 7.4 T: 2°CAssay Description:MIN6 cells [Miyazaki J et al. Endocrinology. 1990 July; 127(1):126-32] were stably transfected with an expression vector for human GPR119 cDNA (Acc. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM180507(US8772323, 69)
Affinity DataEC50:  143nMpH: 7.4 T: 2°CAssay Description:MIN6 cells [Miyazaki J et al. Endocrinology. 1990 July; 127(1):126-32] were stably transfected with an expression vector for human GPR119 cDNA (Acc. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM180543(US8772323, 70)
Affinity DataEC50:  3.91E+3nMpH: 7.4 T: 2°CAssay Description:MIN6 cells [Miyazaki J et al. Endocrinology. 1990 July; 127(1):126-32] were stably transfected with an expression vector for human GPR119 cDNA (Acc. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM180544(US8772323, 71)
Affinity DataEC50: >1.00E+4nMpH: 7.4 T: 2°CAssay Description:MIN6 cells [Miyazaki J et al. Endocrinology. 1990 July; 127(1):126-32] were stably transfected with an expression vector for human GPR119 cDNA (Acc. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM180545(US8772323, 72)
Affinity DataEC50:  1.81E+3nMpH: 7.4 T: 2°CAssay Description:MIN6 cells [Miyazaki J et al. Endocrinology. 1990 July; 127(1):126-32] were stably transfected with an expression vector for human GPR119 cDNA (Acc. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM180546(US8772323, 73)
Affinity DataEC50:  6.77E+3nMpH: 7.4 T: 2°CAssay Description:MIN6 cells [Miyazaki J et al. Endocrinology. 1990 July; 127(1):126-32] were stably transfected with an expression vector for human GPR119 cDNA (Acc. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM180547(US8772323, 74)
Affinity DataEC50:  240nMpH: 7.4 T: 2°CAssay Description:MIN6 cells [Miyazaki J et al. Endocrinology. 1990 July; 127(1):126-32] were stably transfected with an expression vector for human GPR119 cDNA (Acc. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM180548(US8772323, 75)
Affinity DataEC50:  384nMpH: 7.4 T: 2°CAssay Description:MIN6 cells [Miyazaki J et al. Endocrinology. 1990 July; 127(1):126-32] were stably transfected with an expression vector for human GPR119 cDNA (Acc. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM180549(US8772323, 76)
Affinity DataEC50:  245nMpH: 7.4 T: 2°CAssay Description:MIN6 cells [Miyazaki J et al. Endocrinology. 1990 July; 127(1):126-32] were stably transfected with an expression vector for human GPR119 cDNA (Acc. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM180550(US8772323, 77)
Affinity DataEC50:  141nMpH: 7.4 T: 2°CAssay Description:MIN6 cells [Miyazaki J et al. Endocrinology. 1990 July; 127(1):126-32] were stably transfected with an expression vector for human GPR119 cDNA (Acc. ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM180551(US8772323, 78)
Affinity DataEC50:  61nMpH: 7.4 T: 2°CAssay Description:MIN6 cells [Miyazaki J et al. Endocrinology. 1990 July; 127(1):126-32] were stably transfected with an expression vector for human GPR119 cDNA (Acc. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM180552(US8772323, 79)
Affinity DataEC50:  41nMpH: 7.4 T: 2°CAssay Description:MIN6 cells [Miyazaki J et al. Endocrinology. 1990 July; 127(1):126-32] were stably transfected with an expression vector for human GPR119 cDNA (Acc. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM180553(US8772323, 80)
Affinity DataEC50:  615nMpH: 7.4 T: 2°CAssay Description:MIN6 cells [Miyazaki J et al. Endocrinology. 1990 July; 127(1):126-32] were stably transfected with an expression vector for human GPR119 cDNA (Acc. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM180554(US8772323, 81)
Affinity DataEC50:  31nMpH: 7.4 T: 2°CAssay Description:MIN6 cells [Miyazaki J et al. Endocrinology. 1990 July; 127(1):126-32] were stably transfected with an expression vector for human GPR119 cDNA (Acc. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM180555(US8772323, 82)
Affinity DataEC50:  189nMpH: 7.4 T: 2°CAssay Description:MIN6 cells [Miyazaki J et al. Endocrinology. 1990 July; 127(1):126-32] were stably transfected with an expression vector for human GPR119 cDNA (Acc. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM180556(US8772323, 83)
Affinity DataEC50:  94nMpH: 7.4 T: 2°CAssay Description:MIN6 cells [Miyazaki J et al. Endocrinology. 1990 July; 127(1):126-32] were stably transfected with an expression vector for human GPR119 cDNA (Acc. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM180557(US8772323, 84)
Affinity DataEC50:  132nMpH: 7.4 T: 2°CAssay Description:MIN6 cells [Miyazaki J et al. Endocrinology. 1990 July; 127(1):126-32] were stably transfected with an expression vector for human GPR119 cDNA (Acc. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM180558(US8772323, 85)
Affinity DataEC50:  334nMpH: 7.4 T: 2°CAssay Description:MIN6 cells [Miyazaki J et al. Endocrinology. 1990 July; 127(1):126-32] were stably transfected with an expression vector for human GPR119 cDNA (Acc. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM180559(US8772323, 86)
Affinity DataEC50:  1.15E+3nMpH: 7.4 T: 2°CAssay Description:MIN6 cells [Miyazaki J et al. Endocrinology. 1990 July; 127(1):126-32] were stably transfected with an expression vector for human GPR119 cDNA (Acc. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM180560(US8772323, 87)
Affinity DataEC50:  100nMpH: 7.4 T: 2°CAssay Description:MIN6 cells [Miyazaki J et al. Endocrinology. 1990 July; 127(1):126-32] were stably transfected with an expression vector for human GPR119 cDNA (Acc. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM180561(US8772323, 88)
Affinity DataEC50:  260nMpH: 7.4 T: 2°CAssay Description:MIN6 cells [Miyazaki J et al. Endocrinology. 1990 July; 127(1):126-32] were stably transfected with an expression vector for human GPR119 cDNA (Acc. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM180562(US8772323, 89)
Affinity DataEC50:  415nMpH: 7.4 T: 2°CAssay Description:MIN6 cells [Miyazaki J et al. Endocrinology. 1990 July; 127(1):126-32] were stably transfected with an expression vector for human GPR119 cDNA (Acc. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM180563(US8772323, 90)
Affinity DataEC50:  763nMpH: 7.4 T: 2°CAssay Description:MIN6 cells [Miyazaki J et al. Endocrinology. 1990 July; 127(1):126-32] were stably transfected with an expression vector for human GPR119 cDNA (Acc. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM180564(US8772323, 91)
Affinity DataEC50:  142nMpH: 7.4 T: 2°CAssay Description:MIN6 cells [Miyazaki J et al. Endocrinology. 1990 July; 127(1):126-32] were stably transfected with an expression vector for human GPR119 cDNA (Acc. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM180565(US8772323, 92)
Affinity DataEC50:  460nMpH: 7.4 T: 2°CAssay Description:MIN6 cells [Miyazaki J et al. Endocrinology. 1990 July; 127(1):126-32] were stably transfected with an expression vector for human GPR119 cDNA (Acc. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM180566(US8772323, 93)
Affinity DataEC50:  397nMpH: 7.4 T: 2°CAssay Description:MIN6 cells [Miyazaki J et al. Endocrinology. 1990 July; 127(1):126-32] were stably transfected with an expression vector for human GPR119 cDNA (Acc. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM180567(US8772323, 94)
Affinity DataEC50:  114nMpH: 7.4 T: 2°CAssay Description:MIN6 cells [Miyazaki J et al. Endocrinology. 1990 July; 127(1):126-32] were stably transfected with an expression vector for human GPR119 cDNA (Acc. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM180568(US8772323, 95)
Affinity DataEC50:  67nMpH: 7.4 T: 2°CAssay Description:MIN6 cells [Miyazaki J et al. Endocrinology. 1990 July; 127(1):126-32] were stably transfected with an expression vector for human GPR119 cDNA (Acc. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM180569(US8772323, 96)
Affinity DataEC50:  42nMpH: 7.4 T: 2°CAssay Description:MIN6 cells [Miyazaki J et al. Endocrinology. 1990 July; 127(1):126-32] were stably transfected with an expression vector for human GPR119 cDNA (Acc. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM180570(US8772323, 97)
Affinity DataEC50:  225nMpH: 7.4 T: 2°CAssay Description:MIN6 cells [Miyazaki J et al. Endocrinology. 1990 July; 127(1):126-32] were stably transfected with an expression vector for human GPR119 cDNA (Acc. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM180571(US8772323, 98)
Affinity DataEC50:  294nMpH: 7.4 T: 2°CAssay Description:MIN6 cells [Miyazaki J et al. Endocrinology. 1990 July; 127(1):126-32] were stably transfected with an expression vector for human GPR119 cDNA (Acc. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM180572(US8772323, 99)
Affinity DataEC50:  59nMpH: 7.4 T: 2°CAssay Description:MIN6 cells [Miyazaki J et al. Endocrinology. 1990 July; 127(1):126-32] were stably transfected with an expression vector for human GPR119 cDNA (Acc. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM180573(US8772323, 100)
Affinity DataEC50:  442nMpH: 7.4 T: 2°CAssay Description:MIN6 cells [Miyazaki J et al. Endocrinology. 1990 July; 127(1):126-32] were stably transfected with an expression vector for human GPR119 cDNA (Acc. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM180574(US8772323, 101)
Affinity DataEC50:  194nMpH: 7.4 T: 2°CAssay Description:MIN6 cells [Miyazaki J et al. Endocrinology. 1990 July; 127(1):126-32] were stably transfected with an expression vector for human GPR119 cDNA (Acc. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 260 total ) | Next | Last >>
Jump to: